These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
44. Safety and immunogenicity of a parenteral P2-VP8-P[8] subunit rotavirus vaccine in toddlers and infants in South Africa: a randomised, double-blind, placebo-controlled trial. Groome MJ; Koen A; Fix A; Page N; Jose L; Madhi SA; McNeal M; Dally L; Cho I; Power M; Flores J; Cryz S Lancet Infect Dis; 2017 Aug; 17(8):843-853. PubMed ID: 28483414 [TBL] [Abstract][Full Text] [Related]
45. Different dose regimens of a SARS-CoV-2 recombinant spike protein vaccine (NVX-CoV2373) in younger and older adults: A phase 2 randomized placebo-controlled trial. Formica N; Mallory R; Albert G; Robinson M; Plested JS; Cho I; Robertson A; Dubovsky F; Glenn GM; PLoS Med; 2021 Oct; 18(10):e1003769. PubMed ID: 34597298 [TBL] [Abstract][Full Text] [Related]
46. Safety and immunogenicity of a chimpanzee adenovirus-vectored Ebola vaccine in healthy adults: a randomised, double-blind, placebo-controlled, dose-finding, phase 1/2a study. De Santis O; Audran R; Pothin E; Warpelin-Decrausaz L; Vallotton L; Wuerzner G; Cochet C; Estoppey D; Steiner-Monard V; Lonchampt S; Thierry AC; Mayor C; Bailer RT; Mbaya OT; Zhou Y; Ploquin A; Sullivan NJ; Graham BS; Roman F; De Ryck I; Ballou WR; Kieny MP; Moorthy V; Spertini F; Genton B Lancet Infect Dis; 2016 Mar; 16(3):311-20. PubMed ID: 26725450 [TBL] [Abstract][Full Text] [Related]
47. Oral MucoRice-CTB vaccine for safety and microbiota-dependent immunogenicity in humans: a phase 1 randomised trial. Yuki Y; Nojima M; Hosono O; Tanaka H; Kimura Y; Satoh T; Imoto S; Uematsu S; Kurokawa S; Kashima K; Mejima M; Nakahashi-Ouchida R; Uchida Y; Marui T; Yoshikawa N; Nagamura F; Fujihashi K; Kiyono H Lancet Microbe; 2021 Sep; 2(9):e429-e440. PubMed ID: 35544149 [TBL] [Abstract][Full Text] [Related]
55. Immunogenicity and safety of BNT162b2 mRNA vaccine in Chinese adults: A phase 2 randomised clinical trial. Hui AM; Li J; Zhu L; Tang R; Ye H; Lin M; Ge L; Wang X; Peng F; Wu Z; Guo X; Shi Y; Pan H; Zhu J; Song Z; Qiu J; Wang W; Zheng J; Ozhelvaci O; Shpyro S; Bushway M; Derhovanessian E; Kühnle MC; Luxemburger U; Muik A; Shishkova Y; Khondker Z; Hu S; Lagkadinou E; Şahin U; Türeci Ö; Zhu F Lancet Reg Health West Pac; 2022 Dec; 29():100586. PubMed ID: 36120090 [TBL] [Abstract][Full Text] [Related]
56. Safety and immunogenicity of a high-dose quadrivalent influenza vaccine administered concomitantly with a third dose of the mRNA-1273 SARS-CoV-2 vaccine in adults aged ≥65 years: a phase 2, randomised, open-label study. Izikson R; Brune D; Bolduc JS; Bourron P; Fournier M; Moore TM; Pandey A; Perez L; Sater N; Shrestha A; Wague S; Samson SI Lancet Respir Med; 2022 Apr; 10(4):392-402. PubMed ID: 35114141 [TBL] [Abstract][Full Text] [Related]
57. Safety and immunogenicity of two recombinant DNA COVID-19 vaccines containing the coding regions of the spike or spike and nucleocapsid proteins: an interim analysis of two open-label, non-randomised, phase 1 trials in healthy adults. Ahn JY; Lee J; Suh YS; Song YG; Choi YJ; Lee KH; Seo SH; Song M; Oh JW; Kim M; Seo HY; Kwak JE; Youn JW; Woo JW; Shin EC; Sung YC; Park SH; Choi JY Lancet Microbe; 2022 Mar; 3(3):e173-e183. PubMed ID: 35156068 [TBL] [Abstract][Full Text] [Related]
59. Effect of an Inactivated Vaccine Against SARS-CoV-2 on Safety and Immunogenicity Outcomes: Interim Analysis of 2 Randomized Clinical Trials. Xia S; Duan K; Zhang Y; Zhao D; Zhang H; Xie Z; Li X; Peng C; Zhang Y; Zhang W; Yang Y; Chen W; Gao X; You W; Wang X; Wang Z; Shi Z; Wang Y; Yang X; Zhang L; Huang L; Wang Q; Lu J; Yang Y; Guo J; Zhou W; Wan X; Wu C; Wang W; Huang S; Du J; Meng Z; Pan A; Yuan Z; Shen S; Guo W; Yang X JAMA; 2020 Sep; 324(10):951-960. PubMed ID: 32789505 [TBL] [Abstract][Full Text] [Related]
60. A randomized, double-blind, placebo-controlled phase 1 and phase 2 clinical trial to evaluate efficacy and safety of a SARS-CoV-2 vaccine SCoK in adults. Luo D; Pan H; He P; Yang X; Li T; Ning N; Fang X; Yu W; Wei M; Gao H; Wang X; Gu H; Mei M; Li X; Zhang L; Li D; Gao C; Gao J; Fei G; Li Y; Yang Y; Xu Y; Wei W; Sun Y; Zhu F; Hu Z; Wang H Clin Transl Med; 2022 Sep; 12(9):e1016. PubMed ID: 36103390 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]